Feng Xue

24PUBLICATIONS
49CO-AUTHORS
Economic models and forecastingHaematologyEpidemiological methodsAutoimmunityGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Aug 18, 2026
External validation of the AAA+ survival model in a large Chinese cohort with essential thrombocythaemia.

|Jul 01, 2026
Clinical heterogeneity in congenital factor XII deficiency: Coexisting risk factors in thrombotic and bleeding events.

|Jun 15, 2026
Long-term outcomes with emicizumab prophylaxis for haemophilia A in China: A multicentre, large-cohort retrospective study.

|Apr 29, 2026
Low-dose oral nicotinamide mononucleotide for immune thrombocytopenia: a phase 1/2 trial.

|Nov 20, 2025
Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials.

Feng Xue, Mankai Ju, Tienan Zhu

|Oct 21, 2025
Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trial.

Yunfei Chen, Yanmei Xu, Jiawen Dai

Pageof 4

Frequent Collaborators

11 joint publications

Yunfei Chen

10 joint publications

Lei Zhang

8 joint publications

Renchi Yang

8 joint publications

Huan Dong